Literature DB >> 18652443

Blockade of glucocorticoid excess at the tissue level: inhibitors of 11beta-hydroxysteroid dehydrogenase type 1 as a therapy for type 2 diabetes.

Christopher Fotsch1, Minghan Wang.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18652443     DOI: 10.1021/jm800369f

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


× No keyword cloud information.
  10 in total

1.  Derivatives of (phenylsulfonamido-methyl)nicotine and (phenylsulfonamido-methyl)thiazole as novel 11beta-hydroxysteroid dehydrogenase type 1 inhibitors: synthesis and biological activities in vitro.

Authors:  Xu Zhang; Yang Zhou; Yu Shen; Li-li Du; Jun-hua Chen; Ying Leng; Jian-hua Shen
Journal:  Acta Pharmacol Sin       Date:  2009-08-24       Impact factor: 6.150

2.  Optimization of 1,2,4-Triazolopyridines as Inhibitors of Human 11β-Hydroxysteroid Dehydrogenase Type 1 (11β-HSD-1).

Authors:  Jun Li; Lawrence J Kennedy; Haixia Wang; James J Li; Steven J Walker; Zhenqiu Hong; Stephen P O'Connor; Akbar Nayeem; Daniel M Camac; Paul E Morin; Steven Sheriff; Mengmeng Wang; Timothy Harper; Rajasree Golla; Ramakrishna Seethala; Thomas Harrity; Randolph P Ponticiello; Nathan N Morgan; Joseph R Taylor; Rachel Zebo; David A Gordon; Jeffrey A Robl
Journal:  ACS Med Chem Lett       Date:  2014-05-22       Impact factor: 4.345

3.  Ethyl 2-{(2Z)-2-[(1-naphthyl-sulfon-yl)imino]-2,3-dihydro-1,3-thia-zol-4-yl}acetate monohydrate.

Authors:  Gabriel Navarrete-Vázquez; Guadalupe Morales-Vilchis; Samuel Estrada-Soto; Verónica Rodríguez-López; Hugo Tlahuext
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2010-10-09

Review 4.  Current and future drug targets in weight management.

Authors:  Renger F Witkamp
Journal:  Pharm Res       Date:  2010-12-23       Impact factor: 4.200

5.  Discovery of adamantyl heterocyclic ketones as potent 11β-hydroxysteroid dehydrogenase type 1 inhibitors.

Authors:  Xiangdong Su; Nigel Vicker; Mark P Thomas; Fabienne Pradaux-Caggiano; Heather Halem; Michael D Culler; Barry V L Potter
Journal:  ChemMedChem       Date:  2011-05-23       Impact factor: 3.466

6.  Adamantyl ethanone pyridyl derivatives: potent and selective inhibitors of human 11β-hydroxysteroid dehydrogenase type 1.

Authors:  Xiangdong Su; Fabienne Pradaux-Caggiano; Nigel Vicker; Mark P Thomas; Heather Halem; Michael D Culler; Barry V L Potter
Journal:  ChemMedChem       Date:  2011-06-28       Impact factor: 3.466

7.  The regioselective synthesis of spirooxindolo pyrrolidines and pyrrolizidines via three-component reactions of acrylamides and aroylacrylic acids with isatins and α-amino acids.

Authors:  Tatyana L Pavlovskaya; Fedor G Yaremenko; Victoria V Lipson; Svetlana V Shishkina; Oleg V Shishkin; Vladimir I Musatov; Alexander S Karpenko
Journal:  Beilstein J Org Chem       Date:  2014-01-09       Impact factor: 2.883

8.  An inhibitor of 11-β hydroxysteroid dehydrogenase type 1 (PF915275) alleviates nonylphenol-induced hyperadrenalism and adiposity in rat and human cells.

Authors:  Ling-Ling Chang; Wan-Song Alfred Wun; Paulus S Wang
Journal:  BMC Pharmacol Toxicol       Date:  2018-07-18       Impact factor: 2.483

9.  Synthesis of Novel 2-(Isopropylamino)thiazol-4(5H)-one Derivatives and Their Inhibitory Activity of 11β-HSD1 and 11β-HSD2 in Aspect of Carcinogenesis Prevention.

Authors:  Daria Kupczyk; Renata Studzińska; Rafał Bilski; Szymon Baumgart; Renata Kołodziejska; Alina Woźniak
Journal:  Molecules       Date:  2020-09-15       Impact factor: 4.411

10.  Adamantyl carboxamides and acetamides as potent human 11β-hydroxysteroid dehydrogenase type 1 inhibitors.

Authors:  Xiangdong Su; Heather A Halem; Mark P Thomas; Cecile Moutrille; Michael D Culler; Nigel Vicker; Barry V L Potter
Journal:  Bioorg Med Chem       Date:  2012-09-12       Impact factor: 3.641

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.